E2F1-3 proteins appear to have distinct roles in progenitor cells and in differentiating cells undergoing cell cycle exit. However, the function of these proteins in paradigms of terminal differentiation that involve continued cell division has not been examined. Using compound E2F1/E2F2-deficient mice, we have examined the effects of E2F1 and E2F2 loss on the differentiation and simultaneous proliferation of bone-marrow-derived cells toward the macrophage lineage. We show that E2F1/ E2F2 deficiency results in accelerated DNA replication and cellular division during the initial cell division cycles of bone-marrow-derived cells, arguing that E2F1/E2F2 are required to restrain proliferation of pro-monocyte progenitors during their differentiation into macrophages, without promoting their cell cycle exit. Accelerated proliferation is accompanied by early expression of DNA replication and cell cycle regulators. Remarkably, rapid proliferation of E2F1/E2F2 compound mutant cultures is temporally followed by induction of a DNA damage response and the implementation of a p21 CIP1 -dependent senescence. We further show that differentiating E2F1/E2F2-knockout macrophages do not trigger a DNA damage response pathway in the absence of DNA replication. These findings underscore the relevance of E2F1 and E2F2 as suppressors of hematopoietic progenitor expansion. Our data indicate that their absence in differentiating macrophages initiates a senescence program that results from enforcement of a DNA damage response triggered by DNA hyper-replication.
Introduction
Mammalian E2F activity is composed of eight family members that have been traditionally classified into different subsets based on their structural and biochemical characteristics (Dimova and Dyson, 2005) . E2F1-3 are typically known as transcriptional activators and E2F4-8 as transcriptional repressors, although there is increasing evidence suggesting that this division is not as clear-cut as initially proposed. Ectopic expression of E2F1-3 not only leads to transcriptional activation, but also to the repression of numerous genes (Young et al., 2003; Aslanian et al., 2004; Morris et al., 2008) . More convincingly, knockout of E2F2 or compound knockout of E2F1 and E2F2 leads to increased expression of E2F target genes involved in DNA replication and cell cycle progression (Iglesias et al., 2004; Infante et al., 2008; Pusapati et al., 2010) . In addition, knockout of E2F4 leads to decreased expression of target genes such as Ccna2 in erythroid cells (Kinross et al., 2006) . Collectively, these results argue that each individual E2F may be capable of both activating and repressing transcription, through mechanisms that are poorly defined.
Gain-of-function and loss-of-function experiments reveal that the functions of the E2Fs are complex. In line with the original model of E2F function, overexpression of E2F1 in immortalized quiescent rodent fibroblasts results in increased DNA replication and cell proliferation (Lukas et al., 1996) , and overexpression of E2F2 in thymic epithelial cells results in the development of thymomas (Scheijen et al., 2004) . Furthermore, knockout of E2F1 in mouse embryo fibroblasts or in T lymphocytes modestly slows progression from quiescence to S phase (Wang et al., 1998; Murga et al., 2001) , and E2F2
À/À and E2F1/E2F2 À/À mice exhibit impaired hematopoiesis resulting from defective S-phase progression in progenitor populations (Li et al., 2003) . The combined inactivation of E2F1, 2 and 3 completely abolishes entry into S phase and proliferation, along with reduced expression of E2F target genes necessary for these processes (Wu et al., 2001) . These results argue for a positive role for E2F1-3 in cell cycle progression. By contrast, we and others have shown that loss of E2F2, or more dramatically, the combined loss of E2F1 and E2F2 impairs cellular quiescence and leads to accelerated replication of DNA of several cell types, implying a negative role for these proteins in proliferation control (Murga et al., 2001; Zhu et al., 2001; Infante et al., 2008; Pusapati et al., 2010) . Moreover, loss of E2F leads to deficient erythropoiesis, which has been associated with increased DNA double-stranded breaks and cell cycle arrest (Dirlam et al., 2007) , although the source of the DNA damage has not been identified.
Differences in cellular context are likely to modulate the physiological role of E2F1-3. For instance, it has been recently shown that E2F1-3 are dispensable for proliferation, but necessary for cell survival in normally dividing progenitor cells. By contrast, they function as repressors in non-proliferating cells that are undergoing differentiation (Chong et al., 2009) . However, the relative contribution of E2F1-3 in cell survival or in repression has not been determined for cellular contexts where terminal differentiation is not coupled to cell cycle exit, but is instead concurrent with continued proliferation. Such is the case with several lineages of hematopoietic cells, including macrophages, which differentiate from bone-marrow-derived monocytic progenitors while undergoing cellular divisions (Liu et al., 1999) .
To explore the role of E2F1 and E2F2 in proliferating/ differentiating cells, we have made use of hematopoietic progenitor cells lacking E2F1 and E2F2 during their differentiation toward the macrophage lineage in response to macrophage-colony stimulating factor (M-CSF). We show that loss of E2F1 and E2F2 results in accelerated DNA replication and cellular division during the initial cell division cycles of bone-marrowderived cells, arguing that E2F1/E2F2 are not dispensable for normal proliferation of pro-monocyte progenitors during their differentiation into macrophages. Instead, they appear to have a repressor role in this process. Remarkably, rapid proliferation is temporally followed by severe senescence of E2F1/ E2F2 compound mutant cultures without appreciable loss of cellular viability. We further show that accelerated DNA replication triggers a DNA damage response (DDR) pathway in differentiating E2F1/E2F2-knockout macrophages, thus implementing a p21 CIP1 -dependent senescent program. These results add a new layer of complexity to our understanding of E2F1 and E2F2 function, by showing that in some cellular contexts these proteins limit the extent of proliferation without promoting the typical G1 arrest of differentiating cells.
Results
Accelerated proliferation of bone-marrow-derived differentiating macrophages deficient in E2F1 and E2F2 Undifferentiated monocyte progenitor cells derived from the bone marrow constitute a homogeneous population of non-transformed quiescent cells. In response to M-CSF, these cells undergo cell cycle entry and subsequent cell division during their differentiation into bone-marrow-derived macrophages (BMDM) (Liu et al., 1999) , providing a good model for cell cycle studies in mammals. Macrophage maturation is accompanied by the early induction of the differentiation marker CD11b (Mac1) (Brackman et al., 1995) . To determine the role of E2F1 and E2F2 in this process, we studied cells derived from the bone marrow of mice lacking E2F1, E2F2 or both. The percentage of cells expressing high levels of CD11b after 6 days in the presence of M-CSF was close to 80% in both wild-type and mutant cultures ( Figure 1a and data not shown), indicating that E2F1 and E2F2 are dispensable for the expression of macrophage differentiation markers.
To examine proliferation in E2F1
À/À bone-marrow-derived differentiating macrophages, we used the vital fluorescence dye carboxyfluorescein diacetate succinimidyl ester (CFSE), which is diluted approximately twofold with each cell division. Cells were counterstained with an antibody against CD11b to specifically detect macrophages, and were analyzed by flow cytometry. As the population of CD11b hi cells increased over time after M-CSF stimulation, these cells gradually lost their CFSE fluorescence ( Supplementary Figure 1) , confirming that the population undergoing proliferation consisted of differentiating macrophages. Remarkably, a comparison between wild-type and compound E2F1/E2F2 À/À BMDM behaved very differently. They proliferated rapidly during the initial 3 days of culture with M-CSF compared with wild-type cultures, consistent with the CFSE and [ 3 H]thymidine results. However, cell number plateaued by day 4, and thereafter cell number remained constant (Figure 2a) . Upon reaching the plateau on day 4.5, the incorporation of [ 3 H]thymidine was reduced by 75% compared with wild-type controls (Figure 2b ). The rate of apoptosis, however, remained low throughout the experiment in both wildtype and mutant cultures (Figure 2c ). Therefore, we conclude that the plateau in cell number results from proliferation arrest in the E2F1/E2F2
À/À BMDM.
E2F1/E2F2
À/À BMDM cells enter premature senescence The proliferation arrest of E2F1/E2F2 À/À BMDM, without increased apoptosis, raised the possibility that they had entered premature senescence. We measured metabolic activity using the 3-(4,5-dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide assay in BMDM cells after 5 days in culture with M-CSF. We found that E2F1/E2F2 À/À cells remained fully viable and metabolically active (Figure 2d ). We further examined the morphology of E2F1/E2F2 À/À BMDM and found that they were large and flattened relative to wild-type control cells, also suggestive of premature senescence. Finally, we stained the cells for senescence-associated-
À/À or E2F2 À/À BMDM, stained positive for SA-b-gal ( Figure 2e ). All these findings indicate that E2F1/E2F2 À/À BMDM enter senescence after completing a strong proliferative burst.
We hypothesized that cell cycle and/or DNA replication defects during the accelerated proliferation of E2F1/ E2F2 À/À BMDM might be responsible for the premature senescence. Bromodeoxyuridine (BrdU) incorporation analysis showed a higher percentage of cells in the S phase in freshly isolated bone-marrow cells of E2F1/ E2F2 À/À mice relative to wild-type controls (Figure 3b ). The percentage of wild-type bone marrow cells that incorporated BrdU after stimulation with M-CSF increased over time, reaching the peak at day 4 and maintaining similar levels through the end of the experiment on day 6. Interestingly, E2F1/E2F2 À/À cultures treated with M-CSF behaved quite differently. At early time points, the percentage of BrdU-positive cells was significantly higher than wild-type cells (Figures 3a and b ). This increase was consistent with the M-CSF-dependent accelerated proliferation exhibited by E2F1/E2F2 À/À cells during the initial days of cell culture (Figures 1 and 2a) . However, we observed that E2F1/E2F2 À/À cells displayed a marked defect in incorporation of BrdU after days 5 or 6 of stimulation (Figures 3a and b) . Therefore, the E2F1/ E2F2 À/À BMDM had undergone cell cycle arrest. Flow cytometry to compare BrdU incorporation with DNA content revealed that these cells had arrested with a DNA content intermediate between 2N and 4N, suggesting arrest within the S phase, or with an 4N DNA content, suggesting arrest at the G2/M phase (Figures 3a, c and d). Thus, the reduced cellular proliferation of DKO BMDM after the initial burst appears to result from an arrest of the cells at several points of the cell cycle, notably the S and the G2/M phases.
Altered expression of cell cycle regulators in E2F1/E2F2
À/À BMDM To define the mechanisms by which E2F1 and E2F2 regulate proliferation of BMDM, we monitored the expression of known E2F target genes implicated in cell cycle regulation. Bone-marrow cells freshly isolated from wild-type or from compound E2F1/E2F2 À/À mice exhibited similarly low levels of cyclin expression. However, upon differentiation in response to M-CSF, E2F1/E2F2 À/À BMDM showed accelerated accumulation We next examined the expression of E2F target genes implicated in the regulation of DNA replication. Freshly harvested bone-marrow cells from E2F1/E2F2 À/À mice exhibited significantly higher mRNA levels of the DNA replication proteins Mcm3, Cdc6 and Tk relative to freshly harvested wild-type bone-marrow cells (Figure 4b , left panel). One day after M-CSF treatment, high levels of the proteins encoded by these messages were observed in E2F1/E2F2 À/À BMDM (see Figure 6 ). At day 7 of M-CSF treatment, however, mRNA levels of these DNA replication proteins were drastically reduced in E2F1/ E2F2 À/À cells compared with wild-type or single mutant cells (Figure 4b, right panel) .
It has been reported that overexpression of E2F3a is able to induce abnormally increased proliferation, followed by premature senescence (Lazzerini Denchi et al., 2005) . Therefore, we tested whether the E2F1/ E2F2 À/À BMDM exhibit increased expression of E2F3a. However, expression of E2F3a was similar in wild-type and E2F1/E2F2 À/À BMDM (Figure 4c ). CDK inhibitors have been implicated in the induction of cell cycle arrest and cellular senescence (Serrano et al., 1997) . Therefore, we also examined the expression of p16
INK4A
, p19
ARF and p21 CIP1 in E2F1/E2F2 À/À bonemarrow cells (Figure 4d ). Upon differentiation of wildtype macrophages, p16
INK4A and p19 ARF maintained basal levels, whereas the levels of p21 CIP1 were induced significantly, consistently with previously published data (Braun et al., 1998) . However, p21
CIP1 accumulation was significantly higher in E2F1/E2F2 À/À BMDM ( Figure 4d ).
Loss of p21 CIP1 rescues E2F1/E2F2
À/À cells from cellular senescence and restores cell cycle entry and progression The results presented above raised the possibility that p21 CIP1 may be responsible for triggering senescence in E2F1/E2F2
À/À cells. To test this hypothesis, we crossed E2F1/E2F2 À/À mice with p21 CIP1À/À mice to generate triple knockout mice. BMDM were harvested from the triple knockout mice and cultured in the presence of M-CSF in parallel with BMDM from E2F1/E2F2
CIP1À/À and wild-type mice. First, we examined the proliferation of these BMDM cultured in the presence of M-CSF by counting cell number over time (Figure 5a ).
Both the E2F1/E2F2
À/À and E2F1/E2F2/p21 CIP1À/À cells showed accelerated proliferation at the early time point. At subsequent time points, we observed that E2F1/ E2F2 À/À cell number had plateaued, as observed previously. However, mutation of p21 CIP1 in the context Loss of E2F1 and E2F2 leads to DDR and senescence A Iglesias-Ara et al of E2F1/E2F2 À/À eliminated this block in proliferation, allowing an increase in cell number through day 14, proliferating even faster than the wild-type cells. These results were confirmed by [ 3 H]thymidine pulse analysis (Figure 5b ). Nevertheless, young triple knockout mice do not show an increased hematopoietic cellularity (Iglesias et al., unpublished observation) , suggesting that additional mechanisms operate in these mice to prevent aberrantly proliferating cells from expanding in vivo. Furthermore, mice lacking the expression of E2F1/ E2F2/p21 CIP1 develop non-autoimmune diabetes at an early age, and die within 5 months of age, similarly to E2F1/E2F2 DKO mice (Iglesias et al., 2004 and unpublished observation) , hindering analysis of the effect of p21 CIP1 inactivation in older DKO mice. We further examined the S-phase-specific gene expression at day 7 in triple-mutant cells, measuring the levels of Mcm3, Cdc6 and Tk after 7 days in culture ( Figure 5c ). Again, E2F1/E2F2 À/À cells expressed markedly decreased levels of these genes, but additional inactivation of p21 CIP1 restored the expression of these genes. The abnormally large, flat morphology, and SA-b-gal activity observed for E2F1/E2F2
À/À was also prevented by the loss of p21 CIP1 (Figure 5d ), arguing that mutation of p21 CIP1 rescues E2F1/E2F2 À/À BMDM from premature senescence. Thus, E2F1/E2F2 loss induces a p21 CIP1 -dependent senescence program.
DDR activation in E2F1/E2F2
À/À cells Given the altered features exhibited by proliferating E2F1/E2F2
À/À cells, we considered whether they undergo premature cell cycle arrest and cellular senescence as a consequence of activation of the DDR. We examined a marker of the DDR, specifically the accumulation of histone H2AX phosphorylated at serine 139 (referred to as g-H2AX). We performed immunofluorescence with an antibody to g-H2AX in wild-type and E2F1/E2F2 À/À cells exhibiting positive g-H2AX staining, compared with only one nuclear foci per g-H2AX-positive cell in wild-type cultures (Figure 6a) . Likewise, western blotting of cell lysates prepared as early as 1 day after culture with M-CSF revealed a dramatic increase in g-H2AX levels in E2F1/E2F2 À/À BMDM (Figure 6b ). DDR activation initiates a signaling cascade in cells undergoing DNA repair processes, resulting in the stabilization and transcriptional activation of p53 (Shieh et al., 1997) 
. E2F1/E2F2
À/À cultures exhibited accumulation of p53 as early as 1 day after M-CSF treatment (Figure 6b ). Activation of p53 was observed by an increased expression of the p53 target protein p21 CIP1 in E2F1/E2F2 À/À cells (Figure 6b ). Accumulation of g-H2AX and p53 still occurred when p21 CIP1 was deleted (Figures 6a and c) , suggesting that activation of DDR is independent of the status of p21
CIP1
. Interestingly, accumulation of g-H2AX, p53 and p21 CIP1 correlated with (Figures 6b and c) , proteins that function during S phase, suggesting that the aberrant S-phase entry and progression might have triggered DDR in E2F1/E2F2 À/À cells.
Deregulated DNA replication in E2F1/E2F2
À/À cells triggers DDR and induction of p21
CIP1
To address if deregulated DNA replication triggered DDR in E2F1/E2F2
À/À cells, we stimulated bone-marrow-derived cells with M-CSF and treated with aphidicolin to inhibit DNA replication (Xaus et al., 1999) . We first confirmed that aphidicolin treatment blocked DNA replication in a dose-dependent manner (Figure 7a ). Next, we examined the expression of markers of DDR, including g-H2AX, p53 and p21
, as well as expression of the S-phase markers Mcm2 and cyclin A2. As expected, all these genes were expressed in E2F1/E2F2 À/À BMDM (but not in wild-type) 1 day after culture with M-CSF. However, inhibition of DNA replication by aphidicolin prevented the expression of each of these markers in a dose-dependent manner (Figure 7b ), which is parallel to the inhibition of DNA synthesis. These data suggest that the DDR exhibited by E2F1/E2F2 À/À BMDM is a consequence of abnormal DNA replication. Taken together, our data show that deregulated DNA replication occurring after E2F1 and 
Loss of E2F1 and E2F2 leads to DDR and senescence
A Iglesias-Ara et al E2F2 inactivation triggers a DDR pathway that implements a p21 CIP1 -dependent program of senescence.
Discussion
Our results show that loss of E2F1 and E2F2 produces BMDM that undergo accelerated DNA replication and cell proliferation, but that this consequently leads to the activation of DDR and the induction of cellular senescence. Exacerbated DNA replication could account for the increased cell cycle arrest and DNA damage observed in B-cell progenitors and erythroblasts of E2F2-and E2F1/E2F2-deficient mice, which results in impaired hematopoiesis in these mice (Li et al., 2003; Dirlam et al., 2007) . The accelerated initial proliferation Loss of E2F1 and E2F2 leads to DDR and senescence A Iglesias-Ara et al
of E2F1/E2F2
À/À BMDM indicates that normally E2F1 and E2F2 function to suppress proliferation of this cell type. The increased expression in E2F1/E2F2 À/À BMDM of E2F target genes that function in DNA replication and cell cycle progression is the apparent cause of accelerated DNA replication, similar to previous findings in T lymphocytes (Infante et al., 2008) . Furthermore, our results imply that the repressor role of E2F1/E2F2 may not be limited to post-mitotic differentiating cells, a function that has been recently shown for E2F1-3 (Chen et al., 2009; Chong et al.,   2009 ). Instead, they are critical for restraining cellular division in monocyte progenitors during their concomitant differentiation into macrophages. A similar mechanism may be operating in proliferating T cells and keratinocytes lacking E2F2 or E2F1/E2F2 (Murga et al., 2001; Infante et al., 2008; Pusapati et al., 2010) . The role of E2F1/E2F2, and possibly also E2F3, as activators could be limited to ES or early progenitor cells, in which the levels of phosphorylated Rb may be sufficiently high to prevent transcriptional repressor complex recruitment to E2F targets. . WT, E2F1/E2F2 À/À (DKO) and E2F1/E2F2/p21 CIP1À/À (TKO) bone-marrow-derived cells were stimulated with M-CSF. Cells were harvested before and 1 day after stimulation and proteins were analyzed by immunoblotting with the indicated antibodies. Expression of b-actin was used as loading control. These data are representative of at least three experiments.
Loss of E2F1 and E2F2 leads to DDR and senescence A Iglesias-Ara et al A parallel can be drawn between our results and those reported in cancers driven by many oncogenes. It has been suggested that the high levels of DNA replication proteins and G1 cyclins that are found frequently in cancer may contribute to tumorigenesis in part through the aberrant S-phase progression (Ekholm-Reed et al., 2004; Hwang and Clurman, 2005) . Alternatively, the aberrant S-phase progression may actually be tumor suppressive, in that it leads to senescence by activating the DDR. Very rarely, a pre-cancerous cell with aberrant DNA replication could evade this tumor suppressive barrier, such as by mutating p53 (Di Micco et al., 2006) . Activation of the DDR is common in cells and tissues that overexpress oncogenic regulators of cellular proliferation, such as Ras, Braf, mos, cyclin E or E2F3 (Bartkova et al., 2006; Di Micco et al., 2006; Paulson et al., 2008) . It has been suggested that oncogenes cause DNA damage by increasing the production of reactive oxygen species, by telomere attrition, or through the vague concept of replicative stress. Our finding that aphidicolin can block the activation of DDR in E2F1/E2F2
À/À cells has some similarity to other reports implicating aberrant DNA replication in oncogene-induced DNA damage (Bartkova et al., 2006; Di Micco et al., 2006; Paulson et al., 2008) . It is possible that overexpression of the replication proteins Mcm2, Mcm3 and Cdc6 in E2F1/E2F2
À/À cells shown in this study may cause DNA damage by promoting illegitimate replication origin firing, which could, in turn, result in head-to-tail fork collision and checkpoint activation, similarly to what has been shown in cell extracts overexpressing the replication protein Cdt1 (Davidson et al., 2006) .
Cell cycle arrest in E2F1/E2F2 double knockout cells differs from the classical G1 block that has been shown for cells undergoing senescence (Serrano et al., 1997) . A similar block in the G2 or S phases of the cell cycle has been described in cells that undergo senescence upon oncogenic activation (Olsen et al., 2002; Di Micco et al., 2006) . Embryonic fibroblasts carrying inactivating mutations for E2F1-3 also arrest at various phases of the cell cycle, concomitant with induction of p21 and p53 (Timmers et al., 2007) . In these cultures, however, no early proliferative burst or overexpression of E2F target genes was reported. Thus, more than one p53-activating pathway could be induced after single or multiple inactivation of E2F1-3. Our results clearly show that p53 activation in bone-marrow-derived E2F1/ E2F2 À/À hematopoietic cells is triggered by the accelerated DNA replication that occurs during their differentiation into macrophages.
Induction of senescence is thought to involve the p16 INK4A /Rb and p53/p21 CIP1 axes, although the relative contribution of these pathways may vary depending on the cell type or the senescence-triggering signal (Campisi, 2005) . Oncogene-induced senescence, the form of senescence that is most likely to be associated with precancerous lesions (Collado et al., 2005) , has been traditionally linked to increased expression of the cell cycle inhibitors p16 INK4A and p19 ARF in a DDRindependent manner (Lowe et al., 2004) . However, recent evidence from several labs indicates that oncogene overexpression is associated with a DNA replication stress that includes the activation of an ATM-and p53-dependent DNA double-stranded break checkpoint pathway that promotes senescence (Herbig et al., 2004; Di Micco et al., 2006) . Acute loss of Pten or Rb tumor suppressors also induces a p53-dependent senescence pathway (Chen et al., 2005) . The induction of p53-dependent senescence by loss of Rb may be particularly relevant since E2F1 and E2F2 function to tether Rb to DNA to repress transcription. By this model of E2F1 and E2F2 function, we would predict that E2F1/ E2F2À/À cells would exhibit increased transcription of E2F target genes, and p53-dependent senescence. In fact, Loss of E2F1 and E2F2 leads to DDR and senescence A Iglesias-Ara et al we observe that E2F1/E2F2 À/À cells have increased expression of E2F target genes and accumulate p53 and p21 CIP1 , suggesting induction of senescence via the p53-and p21-dependent pathway.
Our data suggest that in bone-marrow-derived macrophages, E2F1 and E2F2 function under normal physiological conditions to restrict cellular proliferation. Their inactivation renders cells prone to aberrant proliferation depending on the status of p21
CIP1
. In cells with an intact p21 CIP1 pathway, this aberrant proliferation results in cell cycle arrest and DDR-induced senescence. However, in the absence of p21 CIP1 these cells proliferate without control in vitro. From the pharmacological point of view, an aberrant cell with an intact p21 CIP1 pathway could benefit from treatments leading to E2F1/2 inactivation, which would push the cells towards inappropriate DNA replication and DDR-induced senescence. However, in situations where the p21 CIP1 -dependent pathway is mutated, we observe that inactivation of E2F1/2 leads to more rapid cell proliferation. Our results suggest that the status of p21 CIP should be taken into account before considering therapies that inactivate the E2F pathway.
Materials and methods

Mouse strains Colonies of E2F1
À/À
, E2F2
À/À and double knockout E2F1/ E2F2 À/À mice have been described (Field et al., 1996; Murga et al., 2001; Iglesias et al., 2004) . p21 CIP1À/À mice (Balomenos et al., 2000) were a kind gift from Dimitrios Balomenos.
Double knockout E2F1/E2F2
À/À mice were bred to p21 CIP1À/À mice to generate triple knockout E2F1/E2F2/p21 CIP1À/À animals. All procedures were approved by the University of the Basque Country Animal Care and Use Committee.
Cell culture and treatments Primary bone-marrow progenitor cells were isolated from tibias and femurs of 4-to-6 week-old mice. Proliferation concomitant to macrophagic differentiation was induced by culture of bone-marrow-derived cells (10 6 /ml) in medium (Dulbecco's modied Eagle's medium with 10% fetal calf serum, 1 Â Pen/Strep) supplemented with 30% L-cell conditioned medium as a source of M-CSF (Celada et al., 1996) . We referred to '30% L-cell conditioned medium' as 'M-CSF', which is equivalent to 10 ng/ml of recombinant M-CSF. Where indicated, cells were treated with aphidicolin (0.25-1 mg/ml; Sigma, St Louis, MO, USA).
S-phase entry, proliferation, apoptosis and cell cycle distribution analyses Bone-marrow-derived cells (10 6 /ml) or differentiated macrophages (10 5 /ml) were cultured in medium alone or medium supplemented with M-CSF. After 24 h, [ 3 H]thymidine (1 mCi/ 100 ml) was added and S-phase entry was measured after 16 h.
For CFSE staining, bone-marrow-derived cells were incubated as described (Infante et al., 2008) , and cultured (10 6 /ml) in medium supplemented with M-CSF. After 1 or 2 days, early differentiating macrophages were detected with cell surface staining, performed using anti-CD11b (Mac1) antibody conjugated to phycoerythrin (Becton & Dickinson, San Jose, CA, USA). Fluorescence was detected and analyzed using a FACSCalibur (Becton & Dickinson) flow cytometer.
For cell cycle distribution analysis, cells were pulse labeled with 10 mM BrdU for the last 30 min of cell culture, washed in ice-cold phosphate-buffered saline and fixed in ice-cold 70% ethanol. Cells were analyzed by flow cytometry as described (Infante et al., 2008) .
Apoptosis of bone-marrow-derived cells (10 6 /ml) cultured in medium supplemented with M-CSF for 3 or 5 days was measured with the Annexin V-FITC Apoptosis Detection Kit II (BD Pharmingen, San Jose, CA, USA) and analyzed by flow cytometry.
Metabolic activity was assayed using the 3-(4,5-dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide-based kit (Sigma) as per the manufacturer's suggested protocol.
Protein and mRNA analyses Protein extracts were prepared as described (Infante et al., 2008) . Antibodies against the following proteins were used in western blots: cyclin D2, cyclin E, cyclin A2, CDK1, Mcm2, p53, p21 CIP1 (Santa Cruz Biotechnologies, Santa Cruz, CA, USA); cyclin B1 (Cell Signalling, Danvers, MA, USA); phospho-histone H2AX (Ser 139; Upstate, Millipore, Billerica, MA, USA) and b-actin (Sigma).
Total RNA was prepared and processed as described (Infante et al., 2008) . Real-time PCR was performed on several cDNA dilutions plus 1 Â SYBR green PCR Master Mix (Applied Biosystems, Carlsbad, CA, USA) and 300-900 nM of primers for Mcm3, Cdc6, Tk, p21 CIP1 , p16 and p19 (sequences provided in Supplementary Table 2). E2F3a expression was determined with a custom-made TaqMan gene expression assay as per the manufacturer's instructions (Applied Biosystems). Reactions were carried out using an ABI Prism 7900 SDS (Applied Biosystems) for 40 cycles (95 1C for 15 s and 60 1C for 1 min) after an initial 10-min incubation at 95 1C. Relative amounts of cDNA were normalized to the internal control Gapdh.
SA-b-gal staining
Equal numbers of wild-type, E2F1
CIP1À/À or E2F1/E2F2/p21 CIP1À/À bone-marrow-derived cells were cultured in medium supplemented with M-CSF. After 5 days, cellular senescence was detected by staining for acidic (pH 6.0) b-galactosidase activity.
Immunofluorescence Bone-marrow-derived cells were cultured in medium supplemented with M-CSF on coverslips. After 2 days, early differentiating macrophages were fixed in 10% paraformaldehyde, permeabilized with 0.2% Triton X-100 and immunostained using 5 mg/ml primary antibody against phospho-histone H2AX (Ser 139; Upstate) and Alexa Fluor 488 (Molecular Probes, Carlsbad, CA, USA) secondary antibody. DNA was counterstained with Hoechst 33288 dye and image analysis was performed using an Olympus Fluoview FV500 microscope and Olympus Flouview 1.7b software.
Statistical analysis
Data are given as mean ± s.d. Statistical analysis was performed using analysis of variance and Fisher's test. Significance was defined by Po0.05.
